BBlogFlow

Mom of 6 Sues Doctors, Hospital After Hysterectomy Allegedly Leads to Paralysis, Quadruple Amputations - Yahoo News Canada

·2d ago
Source: Yahoo News Canada
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

NEED TO KNOWMom of six Trisha Stevens has filed a lawsuit after she developed sepsis following a hysterectomyStevens underwent multiple amputations and became paralyzed after she claims doctors were negligent in providing prompt care, according to the lawsuitThe Portland, Ore., mom is seeking $68.5 million in damages from her medical providersAn Oregon woman underwent multiple amputations and is now paralyzed from the lower back down after she claims her medical teams ignored signs she'd developed a serious infection, per a lawsuit. Portland mom of six, Trisha Stevens, 48, underwent a hysterectomy on Oct. 4, 2024, at Adventist Health Portland, after struggling with abnormal uterine bleeding and adenomyosis, per the complaint. Stevens claims that four days after the surgery, test results showed inflammation, but her doctor, who is named in the suit, allegedly did not review the results or take "any action in response to them, including communicating the results to Ms. Stevens or initiating any additional treatment, follow-up, monitoring based on those findings.

This article is an excerpt. To read the full content, visit the original source. Yahoo News Canada

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·